A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
Clinical trial NCT05689099 · COMPLETED
Trial details
- NCT number
- NCT05689099
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2023-05-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.